Late-stage, Safe, and Effective Orally Delivered Treatment for Sickle Cell Disease Available for World-Wide Licensing

A compelling late stage orally delivered treatment for Sickle Cell Disease with none of the associated side effects of existing treatments, IP protection in place and Orphan drug status awarded in the US and EU....

Early-stage, Novel and Compelling Dual-functional Drug for Improved Treatment of Resistant Colon and Lung Cancers and Chronic Myelogenous (or Myeloid) Leukemia (CML).

A compelling early stage dual functional treatment for resistant colon and lung cancers chronic myelogenous (or myeloid) leukemia with higher efficacy, lower toxicity, and greater ability to combat drug resistance than other clinically available drugs....

Plant Based Treatment for Liver Cirrhosis and Jaundice

Controlling excess bilirubin, SGPT and toxic effects, this treatment targets liver malfunction without the side effects...

Cholesterol and Triglyceride Treatment Without the Typical Side Effects

Available in two small capsules, this treatment proves effective against ischemic heart disease and high cholesterol....

Topical OTC (Europe) and Rx (United States) Diclofenac Pain Relief Product

Using a unique resin-based topical delivery system, this product provides more effective local pain relief and longer periods of sustained relief compared to existing products....

Nicotine Replacement Therapy Product Available to Out-license or Co-develop

This transbuccal (tiny spray on the inside of the cheek) nicotine replacement therapy (NRT) is delivered rapidly into the bloodstream where it provides immediate relief from nicotine cravings....

OTC Safe and Effective Ear Wax Remover

Our client has developed a solution to successfully prevent unwanted earwax buildup....

RhFSH Drug Substance, Highly Similar to Gonal-F®, Requiring Further Development Into Biosimilar to be Used in Fertility Treatments

A biosimilar specialist has manufactured the rhFSH API and is now looking for a partner to fully develop it into a biosimilar comparable to that of Gonal-f®...

Clinical Candidate GABA-based Compounds Based for Neuropathic Pain.

Our Eastern based client has identified a group of compounds that are effective in the treatment of neuropathic chronic pain and have no CNS-related side effects....

Novel Anti-inflammatory Compound with Wound Healing/anaesthetic Properties Suitable for a Wide Range of Dermatological and Dental Applications.

This unique therapeutic topical agent is capable of healing wounds/scars/burns and has many potential uses in the dermatological, dental and hospital/surgery market....

Small Molecule Platform Capable of Enhancing Osteogenic Differentiation of Stem Cells for the Treatment of Bone Disorders.

Scientists at the forefront of regenerative medicine based at the Biomatcell Vinn Excellence Center of Biomaterials have identified this small molecule platform with these unique osteogenic differentiating properties and are now looking to develop them....

Tension Free Vaginal Support (TVS) Medical Device Indicated for Stress Incontinence in Women

Women’s health specialists have created a non invasive class IIa medical device for the successful control of stress related incontinence....

Seeking a Non-Absorbed or Minimally-Absorbed Oral-Route Therapeutic Which Acts On Targets Within the Gut

An IP TechEx Client has an immediate interest in licensing a new oral route therapeutic which acts locally on the gut. Therapeutics for any indication will be considered....

Novel, Ready-to-market, Next Generation of Pain Relief Patch Product Sought for Topical Analgesic Leader

Our analgesic specialists are seeking a new, innovative and novel patch product for the treatment of pain to add to their portfolio....

US Based Animal Health Contract Manufacturer Producing Pharmaceuticals, Nutraceuticals and Medicated Feeds Seeking Customers Globally for Its Services.

Our client is a leading long standing contract manufacturer with expertise in producing pharmaceuticals, nutraceuticals and medicated feed products for the animal health industry....